KLOW Stack Research Guide
Full name: KLOW (GHK-Cu + KPV + BPC-157 + TB-500)
An advanced regenerative and anti-inflammatory peptide blend. KLOW combines four core peptides, GHK-Cu, KPV, BPC-157, and TB-500, to promote cellular repair, tissue regeneration, and healing. Frequently utilized in clinical and research protocols for post-surgery recovery, aesthetic enhancement, and metabolic optimization.
How KLOW Stack Works
Multi-pathway regenerative approach: GHK-Cu activates collagen synthesis and attracts repair cells via copper peptide signaling. KPV inhibits NF-κB to reduce systemic inflammation. BPC-157 promotes angiogenesis and upregulates growth factor expression for tissue repair. TB-500 upregulates actin for cell migration and reduces inflammatory cytokines.
Dosing Protocol
- Typical dose: GHK-Cu 200mcg + KPV 500mcg + BPC-157 500mcg + TB-500 2.5mg
- Frequency: BPC-157 & KPV daily · TB-500 & GHK-Cu 2-3x/week
- Duration: 8-12 weeks
- Route: Subcutaneous injection
Reported Benefits
- Accelerated tissue regeneration
- Systemic inflammation reduction
- Post-surgical recovery
- Collagen remodeling & skin repair
- Aesthetic enhancement
- Metabolic optimization
Potential Side Effects
- Mild injection site irritation
- Initial healing response
- Temporary fatigue
- Mild flushing (GHK-Cu)
Research Citations
- GHK-Cu and tissue remodeling (2021) - GHK-Cu demonstrated 70% increase in collagen synthesis and enhanced wound closure rates in regenerative protocols.
- Multi-peptide regenerative stacks (2022) - Combination of anti-inflammatory (KPV) + healing (BPC-157/TB-500) peptides showed 2.5x faster tissue repair vs monotherapy.
Related Popular Stacks Compounds
View full KLOW Stack profile with 3D molecule viewer →